DNA Oligonucleotides Containing Stereodefined Phosphorothioate Linkages in Selected Positions

Barbara Nawrot1, Beata Rebowska1

1 Department of Bioorganic Chemistry, Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Lodz, Poland
Publication Name:  Current Protocols in Nucleic Acid Chemistry
Unit Number:  Unit 4.34
DOI:  10.1002/0471142700.nc0434s36
Online Posting Date:  March, 2009
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

This unit describes a method for the synthesis of DNA chimeric PO/PS‐oligonucleotides with a stereodefined phosphorothioate bond in the selected position. Diastereomerically pure 5′‐O‐DMTr‐N‐protected‐deoxyribonucleoside‐3′‐O‐(2‐thio‐spiro‐4,4‐pentamethylene‐1,3,2‐oxathiaphospholane)s obtained according to the previously described protocol (UNIT 4.17) are transformed via a stereospecific 1,3,2‐oxathiaphospholane‐ring opening condensation into the corresponding dinucleoside phosphorothioates. Such dimers cannot be introduced into an oligonucleotide chain via the phosphoramidite approach since the unprotected P‐S bond is easily oxidized during routine I2/Py/water oxidation of the phosphite function. In the methodology described here, the reversible alkylation of the PS function is applied. Subsequently, the 3′‐phosphoramidites of such PS‐protected dimers prepared in situ are used for routine synthesis of chimeric PO/PS‐oligonucleotides according to the phosphoramidite method. The presence of the alkylated PS‐function requires modified conditions for oligonucleotide deprotection and cleavage from the solid support. Detailed procedures for the synthesis of PS‐dimers and their incorporation into an oligonucleotide chain, as well as deprotection/purification steps are presented. Curr. Protoc. Nucleic Acid Chem. 36:4.34.1‐4.34.15. © 2009 by John Wiley & Sons, Inc.

Keywords: phosphorothioate oligonucleotide; PS‐oligonucleotide; stereodefined phosphorothioate; oxathiaphospholane; phosphoramidite

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Introduction
  • Basic Protocol 1: Synthesis of Phosphoramidites of Dinucleoside Phosphorothioates from Diastereomerically Pure Nucleoside Oxathiaphospholanes
  • Basic Protocol 2: Synthesis, Deprotection, Isolation, and Characterization of Oligonucleotides Containing Stereodefined Phosphorothioate Bonds
  • Commentary
  • Literature Cited
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol 1: Synthesis of Phosphoramidites of Dinucleoside Phosphorothioates from Diastereomerically Pure Nucleoside Oxathiaphospholanes

  Materials
  • Suitably protected deoxyribonucleosides (ChemGenes):
    • N6‐Benzoyl‐5′‐O‐(4,4′‐dimethoxytrityl)‐2′‐deoxyadenosine (5′‐O‐DMTr‐dABz)
    • N4‐Benzoyl‐5′‐O‐(4,4′‐dimethoxytrityl)‐2′‐deoxycytidine (5′‐O‐DMTr‐dCBz)
    • N2‐Isobutyryl‐5′‐O‐(4,4′‐dimethoxytrityl)‐2′‐deoxyguanosine (5′‐O‐DMTr‐dGi‐Bu)
  • Pyridine (Py; C 6H 5N), anhydrous, 99.8% (Aldrich)
  • Argon (or nitrogen) gas, dry
  • Isopropoxyacetyl anhydride (SinoChemexper or prepared according to Uznański et al., )
  • Chloroform (CHCl 3), HPLC grade
  • Silica gel (230 to 400 mesh)
  • Methanol (CH 3OH), HPLC grade
  • Dichloromethane
  • p‐Toluenesulfonic acid monohydrate, 98% (Aldrich)
  • Tetrahydrofurane (THF), HPLC grade, 99.9% (Aldrich)
  • Diastereoisomerically pure 5′‐O‐DMTr‐deoxynucleoside 3′‐O‐(2‐thio‐spiro‐4,4‐pentamethylene‐1,3,2‐oxathiaphospholane (OTP nucleoside S.1; unit 4.17)
  • Acetonitrile (CH 3CN), anhydrous (Fluka)
  • 1,8‐Diazabicyclo[5.4.0]undec‐7‐ene (DBU; Aldrich)
  • 1,4‐Dioxane anhydrous, 99.8% (Fluka)
  • Ammonium hydroxide, 25% (Baker)
  • 2‐Nitrobenzyl bromide, 98% (Aldrich)
  • Tiethylamine (TEA), anhydrous, HPLC grade (Aldrich)
  • Desiccant silica gel (Aldrich)
  • 2‐Cyanoethyl bis‐(N,N‐diisopropyl)phosphoramidite (prepared according to Caruthers, )
  • 5‐Ethylthio‐1H‐tetrazole, 99% (ChemGenes)
  • 50‐mL and 10‐mL round‐bottom flask
  • Rotary evaporator
  • Membrane vacuum pump
  • High‐vacuum oil pump (0.01 mmHg)
  • Magnetic stir bars and plate
  • Glass columns for chromatography:
    • 20 × 2–cm for 10 g silica gel (230 to 400 mesh)
    • 10 × 1.5–cm for 3 g silica gel (230 to 400 mesh)
  • TLC silica gel plates with UV indicator (Merck)
  • 254‐nm UV lamp
  • 3‐mL and 4‐mL vials
  • Black paper or aluminum foil
  • Rubber septum
  • Luer‐lock needle
  • Desiccator
  • Dry, gas‐tight syringe (previously dried over P 2O 5 in a desiccator for 12 hr)
  • Additional reagents and equipment for TLC ( appendix 3D) and column chromatography ( appendix 3E)

Basic Protocol 2: Synthesis, Deprotection, Isolation, and Characterization of Oligonucleotides Containing Stereodefined Phosphorothioate Bonds

  Materials
  • 3′‐phosphoroamidite of PS‐protected dimer S.6 (see protocol 1, step 38)
  • Commercial 2‐deoxyribonucleoside 3′‐phosphoramidites: 5′‐O‐(4,4′‐Dimethoxytrityl)‐3′‐O‐[(2‐cyanoethoxy)‐(N,N‐diisopropylamino)]phosphinyl thymidine and N‐protected 2′‐deoxy‐cytidine, adenosine and guanosine (Glen Research)
  • Piperidine (Serva)
  • Acetonitrile (CH 3CN), anhydrous (Fluka)
  • Triethylamine (TEA), anhydrous, HPLC grade (Aldrich)
  • 1,4‐Dioxane anhydrous, 99.8% (Fluka)
  • Thiophenol, 99% (Merck)
  • Ethanol
  • 28% concentrated ammonium hydroxide (Baker; appendix 3C)
  • 20% Ethanolic ammonia
  • 40% aqueous methylamine (Aldrich)
  • Buffer A: 1 M triethylammonium bicarbonate (TEAB), pH 7.5
  • Buffer B: 40% acetonitrile/60% buffer A
  • 50% Aqueous acetic acid
  • 50% aqueous ethanol
  • 20% acrylamide/7 M urea gel
  • High‐vacuum oil pump (0.01 mmHg)
  • 4‐mL screw‐cap vial
  • Heat block
  • Benchtop centrifuge
  • 0.2‐µm filter
  • Speedvac evaporator
  • Analytical RP‐HPLC column (e.g., Econosphere C18, 5 µm, 250 × 4.6–mm, Alltech)
  • Vortex
  • Additional reagents and equipment for oligonucleotide synthesis ( appendix 3C), determining DNA concentration by UV spectroscopy (Brown and Brown, ), denaturing polyacrylamide gel electrophoresis ( appendix 3B), and MALDI‐TOF MS (unit 10.1)
NOTE: Solvents possessing ether bonds, such as dioxane or tetrahydrofuran, may contain peroxides. These are very reactive species, able to oxidize phosphorothioate groups into nonchiral phosphate products. Therefore, it is necessary to use highly pure peroxide‐free solvents. The solvents can be purified from peroxides by 24‐hr storage over KOH pellets, followed by careful distillation over LiAlH 4.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

Literature Cited
   Alefelder, S., Patel, B.K., and Eckstein, F. 1998. Incorporation of terminal phosphorothioates into oligonucleotides. Nucl. Acid Res. 26:4983‐4988.
   Azhayev, A.V. 1999. A new universal solid support for oligonucleotide synthesis. Tetrahedron 55:787‐800.
   Brautigam, C. and Steitz, T.A. 1998. Structural principles for the inhibition of the 3′‐5′ exonuclease activity of Escherichia coli DNA polymerase I by phosphorothioates. J. Mol. Biol. 277:363‐377.
   Brown, T. and Brown, D.J.S. 1991. Modern machine‐aided methods of oligodeoxyribonucleotide synthesis. In Oligoncleotides and Analogues. A Practical Approach (F. Eckstein, ed.) pp. 1‐25. Oxford University Press, Oxford.
   Burgers, P.M.J., Eckstein, F., and Hunneman, D.H.J. 1979. Stereochemistry of hydrolysis by snake venom phosphodiesterase. J. Biol. Chem. 254:7476‐7478.
   Caruthers, M.H. 1982. Chemical synthesis of DNA. In Chemical and Enzymatic Synthesis of Gene Fragments. (H.G. Gassen, A. Langs, eds.) pp. 71‐79. Verlag Chemie, Weinheim.
   Caruthers, M.H. 1985. Gene synthesis machines: DNA chemistry and its uses. Science 230:281‐285.
   Cieslak, M., Niewiarowska, J., Nawrot, M., Koziolkiewicz, M., Stec, W.J., and Cierniewski, C.S. 2002. DNAzymes to beta 1 and beta 3 mRNA down‐regulate expression of the targeted integrins and inhibit endothelial cell capillary tube formation in fibrin and matrigel. J. Biol. Chem. 277:6779‐6787.
   Eckstein, F. 2007. Phosphorothioation of DNA in bacteria. Nat. Chem. Biol. 3:689‐690.
   Gait, M. 1984. Oligonucleotide Synthesis, A Practical Approach. IRL Press, Oxford.
   Guga, P., Okruszek, A., and Stec, W.J. 2002. Recent advances in stereocontrolled synthesis of P‐chiral analogues of biophosphates. In Topics in Current Chemistry, Vol. 220 (J.P. Majoral, ed.) pp. 169‐200. Springer Verlag Berlin Heidelberg.
   Guga, P., Boczkowska, M., Janicka, M., Maciaszek, A., Kuberski, S., and Stec, W.J. 2007a. Unusual thermal stability of RNA/[RP‐PS]‐DNA/RNA triplexes containing a homopurine DNA strand. Biophys. J. 92:2507‐2515.
   Guga, P., Janicka, M., Maciaszek, A., Rębowska, B., and Nowak, G. 2007b. Hoogsteen paired homopurine [RP‐PS]‐DNA and homopyrimidine RNA strands form a thermally stable parallel duplex. Biophys. J. 93:3567‐3574.
   Gupta, A., DeBrosse, C., and Benkovic, S.J. 1982. Template‐prime‐dependent turnover of (Sp)‐dATP alpha S by T4 DNA polymerase. The stereochemistry of the associated 3′ goes to 5′‐exonuclease. J. Biol. Chem. 257:7689‐7692.
   Huss, S., Gosselin, G., and Imbach, J.L. 1988. Synthesis of various branched triribonucleoside diphosphates by site‐specific modification of a diphenylcarbamoyl‐protected guanine residue. J. Org. Chem. 53:499‐506.
   Hyodo, M., Ando, H., Nishitani, H., Hattori, A., Hayakawa, H., Kataoka, M., and Hayakawa, Y. 2005. Utility of Azolium Triflates as Promoters for the Condensation of a Nucleoside Phosphoramidite and a Nucleoside in the Agrawal's Stereoselective Synthesis of Nucleoside Phosphorothioates. Eur. J. Org. Chem. 5216‐5223.
   Iwamoto, N., Oka, N., Sato, T., and Wada, T. 2009. Stereocontrolled solid‐phase synthesis of oligonucleoside H‐phosphonates by anoxazaphospholidine approach. Angew. Chem. Int. Ed. Engl. 48:496‐499.
   Iyer, R.P., Yu, D., Ho, N.‐H., Tan, W., and Agrawal, S. 1995. A novel nucleoside phosphoramidite synthon derived from 1R,2S‐ephedrine. Tetrahedron: Asymmetry 6:1051‐1054.
   Iyer, R.P., Guo, M.J., Yu, D., and Agrawal, S. 1998. Solid‐phase stereoselective synthesis of oligonucleoside phosphorothioates: The nucleoside bicyclic oxazaphospholidines as novel synthons. Tetrahedron Lett. 39:2491‐2494.
   Kanehara, H., Mizuguchi, M., and Makino, K. 1996. Isolation of oligodeoxynucleoside phosphorothioate diastereomers by the combination of DEAE ion‐exchange and reversed‐phase chromatography. Nucleosides Nucleotides 15:399‐406.
   Kehler, J., Püschl, A., and Dahl, O. 1997. Solution phase synthesis of dithymidine phosphorothioate by a phosphotriester method using new S‐protecting groups. Nucleosides Nucleotides 16:145‐158.
   Kennedy, A.K., Haniford, D.B., and Mizuuchi, K. 2000. Single active site catalysis of the successive phosphoryl transfer steps by DNA transposases: Insights from phosphorothioate stereoselectivity. Cell 101:295‐305.
   Koziolkiewicz, M., Wójcik, M., Kobylańska, A., Karwowski, B., Rębowska, B., Guga, P., and Stec, W.J. 1997. Stability of stereoregular oligo(nucleoside phosphorothioate)s in human plasma: diastereoselectivity of plasma 3′‐exonuclease. Antisense Nucleic Acid Drug Dev. 7:43‐48.
   Koziolkiewicz, M., Owczarek, A., and Gendaszewska, E. 1999. Enzymatic assignment of diastereomeric purity of stereodefined phosphorothioate oligonucleotides. Antisense Nucleic Acid Drug Dev. 9:171‐181.
   Krieg, A.M., Guga, P., and Stec, W.J. 2003. P‐chirality‐dependent immune activation by phosphorothioate CPG oligodeoxynucleotides. Oligonucleotides 13:491‐499.
   Leeds, J.M., Henry, S.P., Truong, L., Zutshi, A., Levin, A.A., and Kornbrust, D. 1997. Pharmacokinetics of a potential human cytomegalovirus therapeutic, a phosphorothioate oligonucleotide, after intravitreal injection in the rabbit. Drug Metab. Dispos. 25:921‐926.
   Nagarajan, R., Kwon, K., Nawrot, B., Stec, W.J., and Stivers, J.T. 2005. Catalytic phosphoryl interactions of topoisomerase IB. Biochemistry 44:11476‐11485.
   Nawrot, B. and Sipa, K. 2006. Chemical and structural diversity of siRNA molecules. Curr. Top Med. Chem. 6:913‐925.
   Nawrot, B., Rębowska, B., Cieślińska, K., and Stec, W.J. 2005. New approach to the synthesis of oligodeoxyribonucleotides modified with phosphorothioates of predetermined sense of P‐chirality. Tetrahedron Lett. 46:6641‐6644.
   Nawrot, B., Widera, K., Wójcik, M., Rębowska, B., Nowak, G., and Stec, W.J. 2007. Mapping of the functional phosphate groups in the catalytic core of deoxyribozyme 10–23 B. FEBS J. 274:1062‐1072.
   Nawrot, B., Paul, N., Rębowska, B., and Stec, W.J. 2008a. Significance of stereochemistry of 3′‐terminal phosphorothioate‐modified primer in DNA polymerase‐mediated chain extension. Mol. Biotechnol. 40:119‐126.
   Nawrot, B., Rębowska, B., Michalak, O., Bulkowski, M., Błaziak, D., Guga, P., and Stec, W. J. 2008b. 1,3,2‐Oxathiaphospholane approach to the synthesis of P‐Chiral stereodefined analogues of oligonucleotides and biologically relevant nucleoside polyphosphates. Pure Appl. Chem. 80:1859‐1871.
   Nawrot, B., Widera, K., Sobczak, M., Wójcik, M., and Stec, W.J. 2008c. Effect of Rp and Sp phosphorothioate substitution at the scissile Site on the cleavage activity of deoxyribozyme 10‐23. Curr. Org. Chem. 12:1004‐1009.
   Oka, N., Yamamoto, M., Sato, T., and Wada, T. 2008a. Solid‐phase synthesis of stereoregular oligodeoxyribonucleoside phosphorothioates using bicyclic oxazaphospholidine derivatives as monomer units. J. Am. Chem. Soc. 130:16031‐16037.
   Oka, N., Yamamoto, M., Sato, T., and Wada, T. 2008b. Stereocontrolled synthesis of oligonucleoside phosphorothioates and PO/PS‐chimeric oligonucleotides by using oxazaphospholidine derivatives. Nucleic Acids Symp. Ser. (Oxf). 52:335‐336.
   Potter, B.V. and Eckstein, F. 1984. Cleavage of phosphorothioate‐substituted DNA by restriction endonucleases. J. Biol. Chem. 259:14243‐14248.
   Potter, B.V., Connolly, B.A., and Eckstein, F. 1983. Synthesis and configurational analysis of a dinucleoside phosphate isotopically chiral at phosphorus. Stereochemical course of Penicillium citrum nuclease P1 reaction. Biochemistry 22:1369‐1377.
   Shimayama, T., Nishikawa, F., Nishikawa, S., and Taira, K. 1993. Nuclease‐resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages. Nucl. Acids Res. 21:2605‐2611.
   Skerra, A. 1992. Phosphorothioate primers improve the amplification of DNA sequences by DNA polymerases with proofreading activity. Nucl. Acids Res. 20:3551‐3554.
   Stec, W.J. and Wilk, A. 1994. Stereocontrolled synthesis of oligo(nucleoside phosphorothioate)s. Angew. Chem. Int. Ed. Engl. 33:709‐722.
   Stec, W.J., Zon, G., Egan, W., and Stec, B. 1984. Automated solid‐phase synthesis, separation, and stereochemistry of phosphorothioate analogues of oligodeoxyribonucleotides. J. Am. Chem. Soc. 106:6077‐6079.
   Stec, W.J., Zon, G., and Uznański, B. 1985. Reversed‐phase high‐performance liquid chromatographic separation of diastereomeric phosphorothioate analogues of oligodeoxyribonucleotides and other back‐bone‐modified congeners of DNA. J. Chromatogr. 326:263‐280.
   Stec, W.J., Grajkowski, A., Koziolkiewicz, M., and Uznanski, B. 1991. Novel route to oligo(deoxyribonucleoside phosphorothioates). Stereocontrolled synthesis of P‐chiral oligo(deoxyribonucleoside phosphorothioates). Nucl. Acids Res. 19:5883‐5888.
   Stivers, J.T., Nawrot, B., Jagadeesh, G.J., Stec, W.J., and Shuman, S. 2000. Stereochemical outcome and kinetic effects of Rp and Sp‐phosphorothioate substitutions at the cleavage site of vaccinia type I DNA topoisomerase. Biochemistry 39:5561‐5572.
   Syvänen, A. 2005. Toward genome‐wide SNP genotyping. Nat. Genet. 37:S5‐S10.
   Tsuchihashi, Z. and Dracopoli, N.C. 2002. Progress in high throughput SNP genotyping methods. Pharmacogenomics J. 2:103‐110.
   Uznański, B., Grajkowski, A., and Wilk, A. 1989. The isopropoxyacetic group for convenient base protection during solid‐support synthesis of oligodeoxyribonucleotides and their triester analogs. Nucl. Acids Res. 17:4863‐4871.
   Wada, T. 2005. Stereocontrolled synthesis of phosphorothioate DNA by the oxazaphospholidine approach. Frontiers in Organic Chemistry 1:41‐61.
   Wang, L., Chen, S., Xu, T., Taghizadeh, K., Wishnok, J.S., Zhou, X., You, D., Deng, Z., and Dedon, P.C. 2007. Phosphorothioation of DNA in bacteria by dnd genes. Nat. Chem. Biol. 3:709‐710.
   Wilk, A., Grajkowski, A., Phillips, L.R., and Beaucage, S.L. 2000. Deoxyribonucleoside Cyclic N‐Acylphosphoramidites as a New Class of Monomers for the Stereocontrolled Synthesis of Oligothymidylyl‐ and Oligodeoxycytidylyl‐Phosphorothioates. J. Am. Chem. Soc. 122:2149‐2156.
   Zhang, J. and Li, K. 2003. Single‐base discrimination mediated by proofreading 3′ phosphorothioate‐modified primers. Mol. Biotechnol. 25:223‐228.
   Zhang, J., Chen, L.L., Guo, Z.F., Peng, C.Y., Liao, D.F., and Li, K. 2003. On/off switch mediated by Exo+ polymerases: experimental analysis for its physiological and technological implications. J. Biochem. Mol. Biol. 36:529‐532.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library